Significantly reduced CCR2 levels in moderate and severe ALS patients and not in mild variants show that CCR2 may not be causally associated with primary motor neuron degeneration and its pathophysiological involvement could be secondary to neurodegeneration. The gene discussed is CCR2; the disease is amyotrophic lateral sclerosis.